Literature DB >> 11033312

Postnatal treatment with ACTH-(4-9) analog ORG 2766 attenuates N-methyl-D-aspartate-induced excitotoxicity in rat nucleus basalis in adulthood.

K M Horvath1, I M Abrahám, T Harkany, P Meerlo, B G Bohus, C Nyakas, P G Luiten.   

Abstract

It has been reported that the ACTH-(4-9) analog H-Met(O(2))-Glu-His-Phe-D-Lys-Phe-OH (ORG 2766) administered in adulthood has trophic effects on neuronal tissue and when given postnatally, it can induce long-lasting changes in brain development. In the present study, we investigated whether early postnatal treatment with ORG 2766 affects adult neuronal vulnerability, i.e. the sensitivity of cholinergic neurons against excitotoxic damage. Wistar rat pups received injections of ORG 2766 or saline on postnatal days 1, 3 and 5 and were then left undisturbed until adulthood. At the age of 6 months, the animals were subjected to unilateral lesion of magnocellular basal nucleus by infusion of high dose of N-methyl-D-aspartate (NMDA). The effects of the excitotoxic insult were studied 28 hours and 12 days after the lesion by measuring both the acute cholinergic and glial responses, and the final outcome of the degeneration process. Twenty eight hours after NMDA infusion, postnatally ACTH-(4-9)-treated animals showed stronger suppression of choline-acetyltransferase immunoreactivity and increased reaction of glial fibrillary acidic protein -immunopositive astrocytes in the lesioned nucleus compared to control animals. However, 12 days post-surgery, the NMDA-induced loss of cholinergic neurons, as well as the decrease of their acetylcholinesterase -positive fibre projections in the cortex, were less in ACTH-(4-9) animals. Our data indicate that the early developmental effects of ACTH-(4-9) influence intrinsic neuroprotective mechanisms and reactivity of neuronal and glial cells, thereby resulting in a facilitated rescuing mechanism following excitotoxic injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11033312     DOI: 10.1016/s0014-2999(00)00539-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Neonatal administration of ACTH4-10 and its analog Semax to young laboratory mice modulates the number of catecholaminergic neurons in adult animal diencephalon.

Authors:  O S Boyarshinova; A V Revishchin; I I Poletaeva; L I Korochkin
Journal:  Dokl Biol Sci       Date:  2004 May-Jun

2.  Treatment of beta amyloid 1-42 (Aβ(1-42))-induced basal forebrain cholinergic damage by a non-classical estrogen signaling activator in vivo.

Authors:  Andrea Kwakowsky; Kyoko Potapov; SooHyun Kim; Katie Peppercorn; Warren P Tate; István M Ábrahám
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

3.  Immunization with Small Amyloid-β-derived Cyclopeptide Conjugates Diminishes Amyloid-β-Induced Neurodegeneration in Mice.

Authors:  Cornelis K Mulder; Yun Dong; Humphrey F Brugghe; Hans A M Timmermans; Wichard Tilstra; Janny Westdijk; Elly van Riet; Harry van Steeg; Peter Hoogerhout; Ulrich L M Eisel
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

4.  Neuroprotective effect of ACTH on collagenase-induced peri-intraventricular hemorrhage in newborn male rats.

Authors:  Camila A Martins; Laura Tartari Neves; Marina M B P de Oliveira; Pamela Brambilla Bagatini; Rafaela Barboza; Régis Gemerasca Mestriner; Léder Leal Xavier; Alberto A Rasia-Filho
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.